Nu Skin (NUS) EVP Justin Keisel receives 47,059-share equity grant

Rhea-AI Filing Summary

Keisel Justin S reported acquisition or exercise transactions in this Form 4 filing.

NU SKIN ENTERPRISES, INC. executive Justin S. Keisel, EVP and President of Global Sales, received a grant of 47,059 shares of Class A Common Stock. The award was recorded at a price of $0.00 per share, indicating an equity grant rather than an open-market purchase. Following this grant, Keisel directly holds 160,170 shares of Nu Skin Class A Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Keisel Justin S

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, President of Global Sales

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/06/2026		A		47,059	A	$0.00	160,170	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gregory Belliston as Attorney-in-Fact for Justin Keisel	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Nu Skin (NUS) executive Justin S. Keisel report on this Form 4?

Justin S. Keisel reported receiving an equity grant of 47,059 shares of Nu Skin Class A Common Stock. The award was recorded at $0.00 per share, reflecting a grant or award rather than a market transaction, and increased his directly held shares to 160,170.

How many Nu Skin (NUS) shares did Justin S. Keisel acquire in this transaction?

Justin S. Keisel acquired 47,059 shares of Nu Skin Class A Common Stock through a grant or award. This non-cash acquisition increased his direct ownership position, bringing his total directly held shares to 160,170 after the reported transaction was completed.

What is Justin S. Keisel’s role at Nu Skin (NUS) in this Form 4 filing?

In this Form 4, Justin S. Keisel is identified as an officer of Nu Skin, serving as Executive Vice President and President of Global Sales. The reported equity grant reflects compensation tied to his executive role and is held as direct ownership.

Was the Nu Skin (NUS) insider transaction a market purchase or sale?

The transaction was not a market purchase or sale. It was coded as a grant, award, or other acquisition at $0.00 per share, meaning Justin S. Keisel received 47,059 Nu Skin Class A shares as an equity award, rather than buying or selling shares in the open market.

How many Nu Skin (NUS) shares does Justin S. Keisel own after this grant?

After the reported equity grant, Justin S. Keisel directly owns 160,170 shares of Nu Skin Class A Common Stock. This total reflects his updated beneficial ownership position following the award of 47,059 additional shares under the company’s compensation arrangements.